Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) also MASLD, formerly NAFLD
Adult

Hepatology

Useful Management Information

  • GPs seeking guidance on MAFLD assessment and management are advised to consult the Gastroenterology Society of Australia (GESA) MAFLD Consensus Statement, available on the GESA website
  • Manage cardiometabolic risk factors
  • Lifestyle modification (increased activity, dietary, weight, smoking, alcohol)
  • Address misuse of other substance (illicit and prescription drugs)
  • Consider cessation of hepatotoxic medication, complementary and alternative medicines, NSAIDs and benzodiazepines
  • Education: MAFLD-cirrhosis and HCC surveillance

Minimum Referral Criteria

Does your patient meet the minimum referral criteria?
Category 1 (appointment within 30 calendar days)

MAFLD with concerning features:

  • Evidence of liver decompensation (e.g. jaundice and/or ascites and/or encephalopathy)
Category 2 (appointment within 90 calendar days)
  • MAFLD without concerning features and stratified as at high- or unresolved indeterminate-risk of advanced liver fibrosis
  • Assess MAFLD fibrosis stage: begin with first-line FIB-4 score (FIB-4 calculator ) assessment in people aged ≥35 years
    • High risk: FIB-4 score ≥2.7 (or ≥2.0 if over 65 years)
    • Indeterminate risk: FIB-4 score between 1.3 and 2.7. Proceed with second-line tests (liver elastography or serum fibrosis test). Refer if second-line test results are elevated or if these tests are not available

NB: Category 2 cases can be referred to local/regional general physician if gastroenterology access is not locally available

Category 3 (appointment within 365 calendar days)
  • Patients with MAFLD at low risk of advanced liver fibrosis on first line (FIB-4 <1.3) +/- second-line testing without additional cause of liver disease do not require hepatology referral.
  • Ongoing primary care management should include:
    • cardiometabolic risk
    • liver fibrosis reassessment every 2 years or annual monitoring in patients with type 2 diabetes mellitus
  • If the patient does not meet the criteria for referral but the referring practitioner believes the patient requires specialist review, a clinical override may be requested:
    • Please explain why (e.g. warning signs or symptoms, clinical modifiers, uncertain about diagnosis, etc.)
  • Please note that your referral may not be accepted or may be redirected to another service.

Essential Referral Information

  • General referral information including details of presenting issues
  • Comorbidities and past medical history (including cardiometabolic risk factors)
  • Alcohol and drug/medication history (including complementary and alternative medicines)
  • Height, weight and BMI
  • FIB-4 (Fib-4 calculator ), ELFT, FBC results less than 3 months old
  • HBV, HCV serology, fasting glucose, HbA1c and fasting lipid results
  • Recent upper abdominal ultrasound or CT reports

Additional Referral Information

  • Family history of liver disease or diabetes
  • Record of previous liver function tests
  • Iron studies/INR
Last updated 7 October 2025

Send Referrals To

Smart Referrals

Preferred Method
About Smart Referrals

Secure Web Transfer

Send to: Gold Coast Health Service District

Internal Referrals

Hepatology qhRefer

Fax

(07) 5687 4497

Post

Booking and Referral Centre
Gold Coast University Hospital
1 Hospital Boulevard
Southport QLD 4215

Enquiries

1300 559 083

Related HealthPathways

No directly related pathways found

Service Availability

Dr Russell Canavan
Medical Director Hepatology, and Gastroenterology

Facilities

Gold Coast University Hospital

If you would like to send a named referral, please address it to the specialist listed above, who will allocate a suitably qualified specialist to see the patient. Alternatively, you can view a full list of our specialists.

Gold Coast Health - For Clinicians
© The State of Queensland 1995-2021 | Queensland Government
Queensland Government acknowledges the Traditional Owners of the land and pays respect to Elders past, present and future.